Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification.
about
Treatment of high blood pressure and gain in event-free life expectancyDeterminants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence ScaleDoes multimorbidity influence the occurrence rates of chronic conditions? A claims data based comparison of expected and observed prevalence rates.The challenge of controlling systolic blood pressure: data from the National Health and Nutrition Examination Survey (NHANES III), 1988--1994.Use of Pharmacy Sales Data to Assess Changes in Prescription- and Payment-Related Factors that Promote Adherence to Medications Commonly Used to Treat Hypertension, 2009 and 2014.The effect of tai chi exercise on blood pressure: a systematic review.Literacy and blood pressure--do healthcare systems influence this relationship? A cross-sectional study.Antihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects.Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors.Current issues in the management and monitoring of hypertension in chronic kidney disease.Low literacy is associated with uncontrolled blood pressure in primary care patients with hypertension and heart disease.Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use.Applying the 2005 Canadian Hypertension Education Program recommendations: 2. Assessing and reducing global atherosclerotic risk among hypertensive patientsPrevalence of target organ damage in hypertensive subjects attending primary care: C.V.P.C. study (epidemiological cardio-vascular study in primary care).Progression is accelerated from prehypertension to hypertension in blacksCost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: a pharmacoeconomic comparison of antihypertensive efficacy of beta blockersTreatment of hypertension to prevent stroke: translating evidence into clinical practice.Improving blood pressure control in a large multiethnic California population through changes in health care delivery, 2004-2012.Level of blood pressure control among hypertensive patients on follow-up in a regional referral hospital in Central Kenya.Meta-analysis: impact of drug class on adherence to antihypertensives.Arterial hypertension and ischaemic stroke.Hypertensive retinopathy revisited: some answers, more questions.Hypertension and the vascular patient.Efficacy of a Community-Based Physical Activity Program KM2H2 for Stroke and Heart Attack Prevention among Senior Hypertensive Patients: A Cluster Randomized Controlled Phase-II TrialCardiovascular risk in survivors of stroke.Measures of global risk: old versus new methods.Effectiveness of multidisciplinary intervention on blood pressure control in primary health care: a randomized clinical trial.Building on the specialist's antihypertensive treatment recommendation: it's just the beginning.Optimizing hypertension management in clinical practice.A review of stroke in patients with hypertension and coronary artery disease: Focus on calcium channel blockers.Effects of blood pressure reduction on cardiovascular risk estimates in hypertensive postmenopausal women.The importance of managing hypertension and dyslipidemia to decrease cardiovascular disease.Prehypertension and hypertension in a primary care practice.Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination.Medication Adherence and Blood Pressure Control Among Hypertensive Patients With Coexisting Long-Term Conditions in Primary Care Settings: A Cross-Sectional AnalysisHypertension: reflections on risks and prognostication.A review of the phytochemistry and pharmacological activities of raphani semen.Preventing cardiovascular disease among Canadians: is the treatment of hypertension or dyslipidemia cost-effective?Global cardiovascular risk assessment in the management of primary hypertension: the role of the kidneyRecommendations on screening for high blood pressure in Canadian adults
P2860
Q28219249-C5D8B5AD-3570-4694-85B3-728AA37FA0EBQ28487016-8FA76381-DEF5-491D-999C-57CD57D1CD3DQ30571680-E81FCED8-5AB4-4135-8A2B-688DC054871CQ30658320-BFBEC589-FBFA-4E30-ABF3-24D8B47C69C3Q31115388-65BB3A40-C8AB-4179-9084-9CE25D159C96Q33327486-40E6D0C8-E53B-455E-B043-4DE6E628AFFFQ33378978-858A1294-9943-4F56-A5DB-26B1469EC825Q33561456-4C52F420-1FEA-4758-AFD9-126D1A72A421Q33828690-30C890DB-EC95-439A-AEA0-D4287DB20403Q33858915-C92B97B6-4552-4EE4-A9C3-5B6D4BAC96C4Q33915728-0C20FFC6-5850-4751-8C2E-F5E711EC0A67Q33933733-B0629934-E9EC-47BC-9BC6-22540C2EFBEEQ33939576-B55BBB01-38E4-413A-B146-E92D1013DA7EQ33960733-CE8F7F0C-0CF4-4544-86FA-48EE49D613AAQ34215745-676DEBC0-7000-4C5E-9110-2C25FC540AF9Q34247622-CC19BE67-2053-4596-B0E6-445E64C686C2Q34287818-3AE61D43-C379-4532-8F01-005A910D4F5BQ34432791-A1857143-F9E1-4029-91A9-B3379F94367CQ34644804-B57734A5-452E-4D28-8B2E-CD1A9CE91CB6Q34887070-32957B17-B8FF-491C-8B3D-C31E3DA677CAQ35098824-B0788348-E04F-4096-89EB-016A6FBACE6BQ35594054-DAF232C0-002B-493C-A460-59C296C24BE9Q35738465-696F1813-80E4-47A9-AE77-5796E0FD96D8Q35795047-4138CF5E-3C02-498B-A3C7-364CEA08BCC1Q35968346-591C7988-4CA6-4EAB-933A-FF99DE3B5BA5Q36035823-4EFC1A59-EA7A-4639-A71E-3D3C9F506025Q36119110-5FFF549C-9074-4C95-8B93-26269322E99CQ36369680-E9770DFB-DA40-4B1D-A7B2-E15F7E1EB29DQ36568468-53EFF483-ABEF-4D09-A743-16E2C7463306Q36581735-1E81BCB2-9B4D-4BC6-A507-4B8E2D66C0A3Q36761442-34487564-94A3-4AED-866E-D09899DFF906Q36867018-005CBFC8-A8CB-4155-879A-32589B936E1CQ36936509-1D6FD714-B719-4B7F-BAF6-5F02C8C7007EQ36975796-37AE6849-0FDC-4B71-A89F-C2A7F2DAE4C7Q36993060-688A949C-1CDD-4D8A-A103-0C94C20427E4Q37037263-78A9B474-8809-4660-8E42-DB9D71ECA451Q37045140-CF309C12-F67A-4ACC-9E1A-0ED7EAB390BBQ37098508-F8EB8F96-45C6-4DE0-80A4-C0316DBB04A4Q37100961-33EC6E6B-16E5-4304-9568-E74A17E0D8E7Q37167414-4BDF49B0-EF7B-4D1E-8F1B-57E000BDE568
P2860
Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Long-term absolute benefit of ...... he JNC VI risk stratification.
@en
Long-term absolute benefit of ...... he JNC VI risk stratification.
@nl
type
label
Long-term absolute benefit of ...... he JNC VI risk stratification.
@en
Long-term absolute benefit of ...... he JNC VI risk stratification.
@nl
prefLabel
Long-term absolute benefit of ...... he JNC VI risk stratification.
@en
Long-term absolute benefit of ...... he JNC VI risk stratification.
@nl
P2093
P356
P1433
P1476
Long-term absolute benefit of ...... he JNC VI risk stratification.
@en
P2093
P304
P356
10.1161/01.HYP.35.2.539
P407
P577
2000-02-01T00:00:00Z